WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

ACUTE MYELOID LEUKEMIA AFTER TREATMENT WITH RADIOACTIVE IODINE FOR PAPILLARY THYROID CANCER

Gamal Abdul Hamid*, Safa Shukry and Rasha Abbas

ABSTRACT

Radioactive Iodine (RAI) is widely used in the treatment of thyroid cancer. RAI is used after thyroidectomy to ablate the residual normal thyroid remnant, as adjuvant therapy, and to treat thyroid cancer metastases. Leukemia is a rare complication of 131I therapy, usually occurring after cumulative dosages of more than 800 mCi and with intervals between doses of less than 12 months. It occurs in less than 2% of thyroid cancer patients and is associated with a poor therapeutic response and prognosis. We report the occurrence of acute myelogenous leukemia in a 78-yr-old woman had recurrent papillary thyroid carcinoma and long history with radioiodine therapy. Our patient was died after suffering from pancytopenic myeloid leukemia.

Keywords: Thyroid cancer, Radioiodine, Acute myeloid leukemia.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More